Pentixapharm Holding AG (XTER:PTP) FCF Margin %: 0.00% (As of Mar. 2026)


XTER:PTP Pentixapharm Holding AG XTER:PTP
12 GF Score
Price €2.10
! 2 Warning Signs
View Full Analysis

What is Pentixapharm Holding AG FCF Margin %?

Pentixapharm Holding AG XTER:PTP +4.48% 12 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates XTER:PTP with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 960 Biotechnology companies, Pentixapharm Holding AG ranks worse than 95% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Pentixapharm Holding AG's Free Cash Flow for the three months ended in Mar. 2026 was €-2.47 Mil. Pentixapharm Holding AG's Revenue for the three months ended in Mar. 2026 was €0.00 Mil. Therefore, Pentixapharm Holding AG's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Pentixapharm Holding AG's current FCF Yield % is -29.25%.

The historical rank and industry rank for Pentixapharm Holding AG's FCF Margin % or its related term are showing as below:

XTER:PTP' s FCF Margin % Range Over the Past 10 Years
Min: -20571.62   Med: -11720.83   Max: -3668.64
Current: -20571.62

During the past 5 years, the highest FCF Margin % of Pentixapharm Holding AG was -3668.64%. The lowest was -20571.62%. And the median was -11720.83%.

XTER:PTP's FCF Margin % is ranked worse than
95% of 960 companies
in the Biotechnology industry
Industry Median: -85.21 vs XTER:PTP: -20571.62

Pentixapharm Holding AG FCF Margin % Related Terms

Pentixapharm Holding AG FCF Margin % Historical Data

* Premium members only.

The historical data trend for Pentixapharm Holding AG's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pentixapharm Holding AG FCF Margin % Chart

Pentixapharm Holding AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
-6,954.24 -20,141.94 -11,720.83 -3,668.64 -19,997.85

Pentixapharm Holding AG Quarterly Data
Dec21 Dec22 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -30,747.37 -16,721.05 -9,155.70 9,775.00 0.00

XTER:PTP vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Pentixapharm Holding AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pentixapharm Holding AG FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pentixapharm Holding AG's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Pentixapharm Holding AG's FCF Margin % falls into.


XTER:PTP
12GF Score
Pentixapharm Holding AG XTER:PTP
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pentixapharm Holding AG FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Pentixapharm Holding AG's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-18.598/0.093
=-19,997.85 %

Pentixapharm Holding AG's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-2.467/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Pentixapharm Holding AG (XTER:PTP) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Pentixapharm Holding AG and its competitors. According to the industry distribution chart, Pentixapharm Holding AG ranks #912 out of 960 companies in the Biotechnology industry, placing it in the top 95%.
Is Pentixapharm Holding AG's FCF Margin % too high?
Pentixapharm Holding AG's current FCF Margin % is 0.00%. Based on the distribution chart, Pentixapharm Holding AG ranks #912 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Pentixapharm Holding AG has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Pentixapharm Holding AG's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Pentixapharm Holding AG ranks #912 out of 960 companies for FCF Margin %. This places Pentixapharm Holding AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Pentixapharm Holding AG and its competitors. Pentixapharm Holding AG's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pentixapharm Holding AG stock overvalued right now?
Pentixapharm Holding AG (XTER:PTP) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Pentixapharm Holding AG's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Pentixapharm Holding AG (XTER:PTP), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pentixapharm Holding AG Business Description

Other Exchanges PTPN:Austria
Address Robert-Rossle-Street 10, Berlin, DEU, 13125
Pentixapharm Holding AG is a clinical-stage biopharmaceutical company active in the field of research and development of radiopharmaceuticals for diagnostic and therapeutic applications. Radiopharmaceuticals are medical substances containing radioactive elements used in nuclear medicine to diagnose or treat diseases. Its clinical pipeline encompasses PentixaTher, a Yttrium-90 based therapeutic against non-Hodgkin lymphomas (NHL), and PentixaFor, a Gallium-68-based companion diagnostic. Its Pipeline products include: Pentixa Ther, PT-002, PentixaFor, PT-001, PentixaFor, PT-001, PT-00X, GT-001, GT-002, GT-005, GT-008, and GT-00X.
12GF Score

Get the complete analysis for XTER:PTP

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.10
Price